The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Custom Assays Market Research Report 2024
Synopsis
Custom assay is a type of cell or biochemical base provided by assay kits manufacturers to their customers when requested in order to fulfill their needs and purposes.
The global Custom Assays market was valued at US$ 36690 million in 2023 and is anticipated to reach US$ 51450 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
North American market for Custom Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Custom Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Custom Assays in Academic & Research Institutes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Custom Assays include Thermo Fisher Scientific, Bio-Rad, Roche Life Science, Fluidigm, Promega, Merck, GE Healthcare Lifescience, Cisbio and Biosensorix, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Custom Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Custom Assays.
Report Scope
The Custom Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Custom Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Custom Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Rad
Roche Life Science
Fluidigm
Promega
Merck
GE Healthcare Lifescience
Cisbio
Biosensorix
ProeoGenix
Ethos Biosciences
Abzena
Agena Bioscience
Agilent
TissueMetrics
Eurofins Scientific
BioGenes GmbH
Eve Technologies
Quansys Bioscience
Segment by Type
Activity Assays
Competitive Assays
ELISA Assays
Screening Assays
Others
Segment by Application
Academic & Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Contract Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Custom Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Custom assay is a type of cell or biochemical base provided by assay kits manufacturers to their customers when requested in order to fulfill their needs and purposes.
The global Custom Assays market was valued at US$ 36690 million in 2023 and is anticipated to reach US$ 51450 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
North American market for Custom Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Custom Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Custom Assays in Academic & Research Institutes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Custom Assays include Thermo Fisher Scientific, Bio-Rad, Roche Life Science, Fluidigm, Promega, Merck, GE Healthcare Lifescience, Cisbio and Biosensorix, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Custom Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Custom Assays.
Report Scope
The Custom Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Custom Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Custom Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Rad
Roche Life Science
Fluidigm
Promega
Merck
GE Healthcare Lifescience
Cisbio
Biosensorix
ProeoGenix
Ethos Biosciences
Abzena
Agena Bioscience
Agilent
TissueMetrics
Eurofins Scientific
BioGenes GmbH
Eve Technologies
Quansys Bioscience
Segment by Type
Activity Assays
Competitive Assays
ELISA Assays
Screening Assays
Others
Segment by Application
Academic & Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Contract Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Custom Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Custom Assays Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Activity Assays
1.2.3 Competitive Assays
1.2.4 ELISA Assays
1.2.5 Screening Assays
1.2.6 Others
1.3 Market by Application
1.3.1 Global Custom Assays Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academic & Research Institutes
1.3.3 Biopharmaceutical Companies
1.3.4 Diagnostic Centers
1.3.5 Contract Research Organizations
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Custom Assays Market Perspective (2019-2030)
2.2 Custom Assays Growth Trends by Region
2.2.1 Global Custom Assays Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Custom Assays Historic Market Size by Region (2019-2024)
2.2.3 Custom Assays Forecasted Market Size by Region (2025-2030)
2.3 Custom Assays Market Dynamics
2.3.1 Custom Assays Industry Trends
2.3.2 Custom Assays Market Drivers
2.3.3 Custom Assays Market Challenges
2.3.4 Custom Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Custom Assays Players by Revenue
3.1.1 Global Top Custom Assays Players by Revenue (2019-2024)
3.1.2 Global Custom Assays Revenue Market Share by Players (2019-2024)
3.2 Global Custom Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Custom Assays Revenue
3.4 Global Custom Assays Market Concentration Ratio
3.4.1 Global Custom Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Custom Assays Revenue in 2023
3.5 Custom Assays Key Players Head office and Area Served
3.6 Key Players Custom Assays Product Solution and Service
3.7 Date of Enter into Custom Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Custom Assays Breakdown Data by Type
4.1 Global Custom Assays Historic Market Size by Type (2019-2024)
4.2 Global Custom Assays Forecasted Market Size by Type (2025-2030)
5 Custom Assays Breakdown Data by Application
5.1 Global Custom Assays Historic Market Size by Application (2019-2024)
5.2 Global Custom Assays Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Custom Assays Market Size (2019-2030)
6.2 North America Custom Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Custom Assays Market Size by Country (2019-2024)
6.4 North America Custom Assays Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Custom Assays Market Size (2019-2030)
7.2 Europe Custom Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Custom Assays Market Size by Country (2019-2024)
7.4 Europe Custom Assays Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Custom Assays Market Size (2019-2030)
8.2 Asia-Pacific Custom Assays Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Custom Assays Market Size by Region (2019-2024)
8.4 Asia-Pacific Custom Assays Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Custom Assays Market Size (2019-2030)
9.2 Latin America Custom Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Custom Assays Market Size by Country (2019-2024)
9.4 Latin America Custom Assays Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Custom Assays Market Size (2019-2030)
10.2 Middle East & Africa Custom Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Custom Assays Market Size by Country (2019-2024)
10.4 Middle East & Africa Custom Assays Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Custom Assays Introduction
11.1.4 Thermo Fisher Scientific Revenue in Custom Assays Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Detail
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Custom Assays Introduction
11.2.4 Bio-Rad Revenue in Custom Assays Business (2019-2024)
11.2.5 Bio-Rad Recent Development
11.3 Roche Life Science
11.3.1 Roche Life Science Company Detail
11.3.2 Roche Life Science Business Overview
11.3.3 Roche Life Science Custom Assays Introduction
11.3.4 Roche Life Science Revenue in Custom Assays Business (2019-2024)
11.3.5 Roche Life Science Recent Development
11.4 Fluidigm
11.4.1 Fluidigm Company Detail
11.4.2 Fluidigm Business Overview
11.4.3 Fluidigm Custom Assays Introduction
11.4.4 Fluidigm Revenue in Custom Assays Business (2019-2024)
11.4.5 Fluidigm Recent Development
11.5 Promega
11.5.1 Promega Company Detail
11.5.2 Promega Business Overview
11.5.3 Promega Custom Assays Introduction
11.5.4 Promega Revenue in Custom Assays Business (2019-2024)
11.5.5 Promega Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Custom Assays Introduction
11.6.4 Merck Revenue in Custom Assays Business (2019-2024)
11.6.5 Merck Recent Development
11.7 GE Healthcare Lifescience
11.7.1 GE Healthcare Lifescience Company Detail
11.7.2 GE Healthcare Lifescience Business Overview
11.7.3 GE Healthcare Lifescience Custom Assays Introduction
11.7.4 GE Healthcare Lifescience Revenue in Custom Assays Business (2019-2024)
11.7.5 GE Healthcare Lifescience Recent Development
11.8 Cisbio
11.8.1 Cisbio Company Detail
11.8.2 Cisbio Business Overview
11.8.3 Cisbio Custom Assays Introduction
11.8.4 Cisbio Revenue in Custom Assays Business (2019-2024)
11.8.5 Cisbio Recent Development
11.9 Biosensorix
11.9.1 Biosensorix Company Detail
11.9.2 Biosensorix Business Overview
11.9.3 Biosensorix Custom Assays Introduction
11.9.4 Biosensorix Revenue in Custom Assays Business (2019-2024)
11.9.5 Biosensorix Recent Development
11.10 ProeoGenix
11.10.1 ProeoGenix Company Detail
11.10.2 ProeoGenix Business Overview
11.10.3 ProeoGenix Custom Assays Introduction
11.10.4 ProeoGenix Revenue in Custom Assays Business (2019-2024)
11.10.5 ProeoGenix Recent Development
11.11 Ethos Biosciences
11.11.1 Ethos Biosciences Company Detail
11.11.2 Ethos Biosciences Business Overview
11.11.3 Ethos Biosciences Custom Assays Introduction
11.11.4 Ethos Biosciences Revenue in Custom Assays Business (2019-2024)
11.11.5 Ethos Biosciences Recent Development
11.12 Abzena
11.12.1 Abzena Company Detail
11.12.2 Abzena Business Overview
11.12.3 Abzena Custom Assays Introduction
11.12.4 Abzena Revenue in Custom Assays Business (2019-2024)
11.12.5 Abzena Recent Development
11.13 Agena Bioscience
11.13.1 Agena Bioscience Company Detail
11.13.2 Agena Bioscience Business Overview
11.13.3 Agena Bioscience Custom Assays Introduction
11.13.4 Agena Bioscience Revenue in Custom Assays Business (2019-2024)
11.13.5 Agena Bioscience Recent Development
11.14 Agilent
11.14.1 Agilent Company Detail
11.14.2 Agilent Business Overview
11.14.3 Agilent Custom Assays Introduction
11.14.4 Agilent Revenue in Custom Assays Business (2019-2024)
11.14.5 Agilent Recent Development
11.15 TissueMetrics
11.15.1 TissueMetrics Company Detail
11.15.2 TissueMetrics Business Overview
11.15.3 TissueMetrics Custom Assays Introduction
11.15.4 TissueMetrics Revenue in Custom Assays Business (2019-2024)
11.15.5 TissueMetrics Recent Development
11.16 Eurofins Scientific
11.16.1 Eurofins Scientific Company Detail
11.16.2 Eurofins Scientific Business Overview
11.16.3 Eurofins Scientific Custom Assays Introduction
11.16.4 Eurofins Scientific Revenue in Custom Assays Business (2019-2024)
11.16.5 Eurofins Scientific Recent Development
11.17 BioGenes GmbH
11.17.1 BioGenes GmbH Company Detail
11.17.2 BioGenes GmbH Business Overview
11.17.3 BioGenes GmbH Custom Assays Introduction
11.17.4 BioGenes GmbH Revenue in Custom Assays Business (2019-2024)
11.17.5 BioGenes GmbH Recent Development
11.18 Eve Technologies
11.18.1 Eve Technologies Company Detail
11.18.2 Eve Technologies Business Overview
11.18.3 Eve Technologies Custom Assays Introduction
11.18.4 Eve Technologies Revenue in Custom Assays Business (2019-2024)
11.18.5 Eve Technologies Recent Development
11.19 Quansys Bioscience
11.19.1 Quansys Bioscience Company Detail
11.19.2 Quansys Bioscience Business Overview
11.19.3 Quansys Bioscience Custom Assays Introduction
11.19.4 Quansys Bioscience Revenue in Custom Assays Business (2019-2024)
11.19.5 Quansys Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
